Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 09, 2021 16:30 ET | Source: iBio, Inc.

iBio to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Update on Tuesday, February 16, 2021

BRYAN, Texas, Feb. 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it will...
December 28, 2020 07:30 ET | Source: iBio, Inc.

iBio Appoints Dr. Martin B. Brenner as Chief Scientific Officer

BRYAN, Texas, Dec. 28, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the...
December 10, 2020 16:30 ET | Source: iBio, Inc.

iBio Announces Closing of its Public Offering of Common Stock

BRYAN, Texas, Dec. 10, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the closing...
December 08, 2020 08:55 ET | Source: iBio, Inc.

iBio Announces Pricing of $35 Million Public Offering of Common Stock

BRYAN, Texas, Dec. 08, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the pricing...
December 07, 2020 16:01 ET | Source: iBio, Inc.

iBio Announces Proposed Public Offering of Common Stock

BRYAN, Texas, Dec. 07, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced an...
December 01, 2020 16:30 ET | Source: iBio, Inc.

iBio Selected to Produce ATB Therapeutics’ Bioengineered Antibody-Toxin Fusion Proteins

BRYAN, Texas, Dec. 01, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract development and manufacturing organization (“CDMO”),...
November 24, 2020 07:30 ET | Source: iBio, Inc.

iBio Announces Issuance of U.S. Patent Covering Endostatin Peptides for Treating Fibrosis

BRYAN, Texas, Nov. 24, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that the...
November 16, 2020 16:05 ET | Source: iBio, Inc.

iBio Reports Fiscal First Quarter 2021 Financial Results and Provides Corporate Update

BRYAN, Texas, Nov. 16, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its...
November 12, 2020 08:00 ET | Source: iBio, Inc.

iBio to Participate in Alliance Global Partners’ Virtual Healthcare Symposium

BRYAN, Texas, Nov. 12, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that...
November 05, 2020 16:30 ET | Source: iBio, Inc.

iBio to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Update on Monday, November 16 ,2020

BRYAN, Texas, Nov. 05, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it will...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right